Thomas Meyer
Impact in
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 46
- Cutaneous Melanoma Detection and Management 11
- HER2/EGFR in Cancer Research 9
- Pancreatic and Hepatic Oncology Research 8
- Cancer-related Molecular Pathways 7
-
- PI3K/AKT/mTOR signaling in cancer 10
- Co-authors
- Helmut Mett (15 shared papers)Elisabeth Buchdunger (12 shared papers)Doriano Fabbro (27 shared papers)Nicholas Lydon (11 shared papers)Jürg Zimmermann (7 shared papers)Pascal Furet (20 shared papers)Paul William Manley (11 shared papers)Ann G. Depicker (8 shared papers)
- Journals
- Journal of Medicinal Chemistry (12 papers)Bioorganic & Medicinal Chemistry Letters (10 papers)European Journal of Surgical Oncology (5 papers)Strahlentherapie und Onkologie (4 papers)Cancer Research (3 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Thomas Meyer
143 papers receiving 8.6k citations
Thomas Meyer's Hit Papers
Peers
Comparison fields: 5 of 148
- Hematology 1.7k
- Genetics 1.1k
- Oncology 2.1k
- Toxicology 233
- Molecular Biology 3.8k
Countries citing papers authored by Thomas Meyer
This map shows the geographic impact of Thomas Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Meyer more than expected).
Fields of papers citing papers by Thomas Meyer
This network shows the impact of papers produced by Thomas Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Meyer. The network helps show where Thomas Meyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Hit paper breakdown → | 1996 | 932 |
| 2 | 2002 | 523 | |
| 3 | 2004 | 474 | |
| 4 | 2014 | 387 | |
| 5 | 2004 | 285 | |
| 6 | 2005 | 282 | |
| 7 | 2014 | 261 | |
| 8 | 1995 | 257 | |
| 9 | 2002 | 220 | |
| 10 | 1997 | 210 | |
| 11 | 1997 | 196 | |
| 12 | 2007 | 190 | |
| 13 | 2003 | 189 | |
| 14 | 1994 | 177 | |
| 15 | 2004 | 152 | |
| 16 | 1996 | 139 | |
| 17 | 1999 | 129 | |
| 18 | 1996 | 129 | |
| 19 | 1996 | 124 | |
| 20 | 2003 | 122 |
About Thomas Meyer
Thomas Meyer is a scholar working on Oncology, Molecular Biology, Hematology, Organic Chemistry and Toxicology, having authored 145 papers that have together received 9.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (13 papers), Cutaneous Melanoma Detection and Management (11 papers), PI3K/AKT/mTOR signaling in cancer (10 papers), Quinazolinone synthesis and applications (10 papers), HER2/EGFR in Cancer Research (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), Nanoparticles: synthesis and applications (8 papers) and Cancer-related Molecular Pathways (7 papers). The work is most often cited by research in Hematology (1.7k citations), Genetics (1.1k citations), Oncology (2.1k citations), Toxicology (233 citations) and Molecular Biology (3.8k citations). Thomas Meyer has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Helmut Mett, Elisabeth Buchdunger, Doriano Fabbro, Nicholas Lydon, Jürg Zimmermann, Pascal Furet, Paul William Manley, Ann G. Depicker, Marcel Müller and Brian J. Druker. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, European Journal of Surgical Oncology, Strahlentherapie und Onkologie and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.